An aspirin a day may slow brain decline in elderly women at high risk of cardiovascular disease, research finds.
The study authors estimated that for patients with a high risk of cardiovascular disease, there were 245 extra deaths per million people treated.
In fact, it is running what could be the definitive test of fish oil-based drugs: a study of whether adding Vascepa to a statin medicine in patients with high triglycerides reduces the risk of cardiovascular disease.
FORBES: Could A Fish Oil Backlash Wash Out Amarin Pharmaceuticals?
After controlling for other factors which might influence heart disease risk, they found that high levels of distress at age seven were associated with a 31% increased risk of cardiovascular disease in middle-aged women.
Investigators in Spain randomized 7447 people at high risk for cardiovascular disease to one of three diets: a Mediterranean diet supplemented with extra-virgin olive oil, a Mediterranean diet supplemented with nuts, or a control diet for which people were advised to lower their intake of dietary fat.
FORBES: Large Trial Shows Cardiovascular Benefits Of Mediterranean Diet
Researchers, for example, recently showed for the first time that a Mediterranean diet can have as powerful an effect as drugs in preventing heart attacks, strokes and deaths from cardiovascular disease in subjects at high risk of heart disease.
For men with high levels of distress in childhood - which included being easily frustrated and quick to anger - the increased risk of cardiovascular disease was 17%.
Individuals with high triglyceride levels should undergo further assessment of other cardiovascular risk factors, such as obesity, hypertension, abnormal glucose metabolism, and liver dysfunction.
Enhanced cardiovascular protective effects of valsartan in high-risk hypertensive patients with left ventricular hypertrophy: Sub-analysis of the KYOTO HEART study.
FORBES: Two Retractions For Embattled Chief Investigator Of Kyoto Heart Study
Effects of valsartan on cardiovascular morbidity and mortality in high-risk hyper- tensive patients with new-onset diabetes mellitus: Sub-analysis of the KYOTO HEART Study.
FORBES: Two Retractions For Embattled Chief Investigator Of Kyoto Heart Study
After years of controversy, the Food and Drug Administration has asked Abbott Laboratories to yank the weight loss drug Meridia, generically known as sibutramine, from the market as a result of a large clinical trial that found the drug increased the rate of heart attack and stroke in patients at high cardiovascular risk.
Novartis announced today the early termination of the ALTITUDE trial, which was testing the effect of the direct renin inhibitor aliskiren (Rasilez, Tekturna) in type 2 diabetics at high risk for cardiovascular and renal events.
FORBES: ALTITUDE Study of Aliskiren Terminated Early by Novartis
The bottom line is this: why even take the risk of developing a kidney stone-with its attendant pain and suffering-if high dose vitamin C has never been proven to have beneficial effects on our quality of health and risk for developing cardiovascular disease as well as cancer?
Stein also noted that researchers found that although the medication given to the participants could reduce cardiovascular events in high-risk patients, the drugs didn't influence the course or the development of ED.
应用推荐